Tybourne Capital Management

Tybourne Capital Management is a Hong Kong-based investment firm specializing in long/short equity strategies across both public and private markets. Founded in 2012 by Eashwar Krishnan and Tanvir Ghani, the firm has established itself as a significant player in the investment landscape. The firm's investment approach is characterized by a fundamental analysis of companies, focusing on identifying growth opportunities in various sectors and stages. Tybourne has a history of making substantial investments in both public and private companies, demonstrating a versatile investment strategy. Over the years, Tybourne has built a diverse portfolio, including notable private investments in companies such as Amylyx Pharmaceuticals, Freecharge, Paidy, and Snapdeal. The firm's commitment to delivering value to its investors is evident in its strategic investment choices and consistent performance in the market.

Strong management teams, Scalable business models, Clear growth trajectories, Competitive market positions, Innovative products or services